HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A trial of growth hormone therapy in well-controlled hypophosphataemic rickets.

AbstractOBJECTIVE:
Conventional therapy of hypophosphataemic rickets (HR) with oral phosphate and calcitriol does not always result in normal linear growth. Recombinant human growth hormone (rhGH) offers theoretical advantages as an adjunctive therapy. We aimed to determine the effects of adjunctive rhGH therapy in children with well-controlled HR.
PATIENTS:
In this report, 5 prepubertal children (aged 3.5-10.9 years) with well-controlled HR on conventional therapy were given adjunctive standard dose rhGH therapy for one year.
DESIGN AND MEASUREMENTS:
Height, growth velocity, metabolic markers of calcium and phosphate metabolism, body composition, bone mineral density, wrist and knee X-rays, and renal sonography were assessed at regular intervals. Height and growth velocities were also calculated 12 months after ceasing rhGH therapy.
RESULTS:
After 12 months therapy with rhGH, no significant biochemical or radiological benefits were observed. A significant increase in height SD score was observed (P = 0.023), but this was not associated with any increase in the growth velocity SD score and appears to have been due to catch-up growth caused by conventional therapy alone. When rhGH therapy was ceased, no significant decreases in mean height SD or growth velocity SD scores were observed.
CONCLUSIONS:
In well-controlled hypophosphataemic rickets patients receiving conventional therapy, adjunctive therapy with standard dose rhGH offers no benefits in linear growth or rachitic disease markers.
AuthorsF J Cameron, E B Sochett, A Daneman, S W Kooh
JournalClinical endocrinology (Clin Endocrinol (Oxf)) Vol. 50 Issue 5 Pg. 577-82 (May 1999) ISSN: 0300-0664 [Print] England
PMID10468922 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Phosphates
  • Growth Hormone
  • Calcitriol
Topics
  • Body Composition (drug effects)
  • Body Height (drug effects)
  • Bone Density (drug effects)
  • Calcitriol (therapeutic use)
  • Child
  • Child, Preschool
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Growth Hormone (therapeutic use)
  • Humans
  • Hypophosphatemia, Familial (drug therapy, metabolism, physiopathology)
  • Male
  • Phosphates (metabolism, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: